Biotech & MedTech News
-
Zentek Announces Preliminary Battery Results and University of Toronto Receives NSERC Mission Alliance Grant to Optimize Graphite for Battery Anode Use
August 8, 2024 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization…
-
Zentek Launches National Sampling Program for ZenGUARD(TM) Antimicrobial Surgical Masks
July 24, 2024 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company…
-
Zentek Announces Non-Brokered Private Placement of Units for up to $3 Million
July 23, 2024 (Source) — Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) (“Zentek” or the “Company”), an intellectual property development…
-
JanOne Announces Plan to Enhance Stockholder Value Through Strategic Realignment
-The board has approved a strategic review of the biotech assets and ALT5 Sigma being the core focus…
-
Voyageur Pharmaceuticals Grants Deferred Share Units
July 9, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC: VYYRF) (“Voyageur” or the “Corporation”), a provider…
-
Zentek Announces Grant of Stock Options
June 21, 2024 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN) announces the granting of options to acquire…
-
Coeptis Therapeutics Closes on $4.3 Million of Series A Preferred Offering
Bolsters Company’s Corporate Mission Financing Led by Board Member and Priced at Premium to Market Price June 20,…
-
Testing to Begin of Radiology Endohedral Fullerenes, a Milestone in Nanotechnology & Drug Development
June 11, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (“Voyageur” or the “Company”) announces that…
-
DIAGNOS Announces Closing of Second and Final Tranche of Private Placement
June 5, 2024 (Source) — DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer…
-
Coeptis Therapeutics’ Dr. Colleen Delaney to Present at Allogeneic Cell Therapies Summit 6th Annual Meeting
May 30, 2024 (Source) — Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the “Company” or “Coeptis”), a biopharmaceutical company developing…
